{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:01:19Z","timestamp":1789585279248,"version":"build-2803163510"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T00:00:00Z","timestamp":1775865600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["PNC-E3\\u20132022\\u201323683266"],"award-info":[{"award-number":["PNC-E3\\u20132022\\u201323683266"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["GR-2018\\u201312365610"],"award-info":[{"award-number":["GR-2018\\u201312365610"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["T4-AN-09"],"award-info":[{"award-number":["T4-AN-09"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008088","name":"Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008088","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018985","name":"Waalse Gewest","doi-asserted-by":"publisher","award":["SPW-EER\/DRDT\/DPjR\/DEMO\/ML\/ D\\u00E9f-8296"],"award-info":[{"award-number":["SPW-EER\/DRDT\/DPjR\/DEMO\/ML\/ D\\u00E9f-8296"]}],"id":[{"id":"10.13039\/100018985","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.phrs.2026.108193","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T20:34:18Z","timestamp":1776112458000},"page":"108193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["PPAR\u03b3 activation by leriglitazone counteracts neurodegeneration and neuroinflammation in a disease-relevant mouse model of COASY dysfunction"],"prefix":"10.1016","volume":"227","author":[{"given":"Chiara","family":"Cavestro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Floriana","family":"Cascone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Legati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossella","family":"Izzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcella","family":"Catania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Vergara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Rodr\u00edguez-Pascau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Pizcueta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Tiranti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4616-5623","authenticated-orcid":false,"given":"Ivano","family":"Di Meo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2026.108193_bib1","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.plipres.2005.04.001","article-title":"Coenzyme A: back in action","volume":"44","author":"Leonardi","year":"2005","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.phrs.2026.108193_bib2","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1042\/BST20140125","article-title":"Coenzyme A, more than `just\u2019 a metabolic cofactor","volume":"42","author":"Srinivasan","year":"2014","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.phrs.2026.108193_bib3","first-page":"E1","article-title":"Coenzyme A metabolism","volume":"248","author":"Robishaw","year":"1985","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.phrs.2026.108193_bib4","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1038\/s42255-024-01059-y","article-title":"Coenzyme A biosynthesis: mechanisms of regulation, function and disease","volume":"6","author":"Barritt","year":"2024","journal-title":"Nat. Metab."},{"key":"10.1016\/j.phrs.2026.108193_bib5","doi-asserted-by":"crossref","unstructured":"A. Zhyvoloup, I. Nemazanyy, A. Babich, G. Panasyuk, N. Pobigailo, M. Vudmaska, V. Naidenov, O. Kukharenko, S. Palchevskii, L. Savinska, G. Ovcharenko, F. Verdier, T. Valovka, T. Fenton, H. Rebholz, M.-L. Wang, P. Shepherd, G. Matsuka, V. Filonenko, I.T. Gout, 2002, Molecular cloning of CoA Synthase. The missing link in CoA biosynthesis., The Journal of Biological Chemistry 277 (2002) 22107\u201322110. https:\/\/doi.org\/10.1074\/jbc.C200195200.","DOI":"10.1074\/jbc.C200195200"},{"key":"10.1016\/j.phrs.2026.108193_bib6","doi-asserted-by":"crossref","first-page":"5951","DOI":"10.3390\/ijms24065951","article-title":"Inherited disorders of Coenzyme A biosynthesis: models, mechanisms, and treatments","volume":"24","author":"Cavestro","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2026.108193_bib7","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ng572","article-title":"A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome","volume":"28","author":"Zhou","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.phrs.2026.108193_bib8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ajhg.2013.11.008","article-title":"Exome sequence reveals mutations in CoA synthase as a cause of neurodegeneration with brain iron accumulation","volume":"94","author":"Dusi","year":"2014","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.phrs.2026.108193_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpn.2018.01.008","article-title":"Classification and molecular pathogenesis of NBIA syndromes","author":"Di Meo","year":"2018","journal-title":"Eur. J. Paediatr. Neurol. EJPN Off. J. Eur. Paediatr. Neurol. Soc."},{"key":"10.1016\/j.phrs.2026.108193_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/acn3.52079","article-title":"Emerging variants, unique phenotypes, and transcriptomic signatures: an integrated study of COASY-associated diseases","author":"Cavestro","year":"2024","journal-title":"Ann. Clin. Transl. Neurol. N.\/a"},{"key":"10.1016\/j.phrs.2026.108193_bib11","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s12098-023-04515-x","article-title":"Status epilepticus in coenzyme a synthase protein-associated neurodegeneration - Expanding the clinical phenotype","volume":"90","author":"Ajit","year":"2023","journal-title":"Indian J. Pedia"},{"key":"10.1016\/j.phrs.2026.108193_bib12","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/mdc3.13624","article-title":"A mild form of neurodegeneration with brain iron accumulation attributed to Coenzyme A synthase mutation","volume":"10","author":"Hashemi","year":"2023","journal-title":"Mov. Disord. Clin. Pract."},{"key":"10.1016\/j.phrs.2026.108193_bib13","doi-asserted-by":"crossref","first-page":"834","DOI":"10.4103\/aian.aian_456_23","article-title":"COASY protein-associated neurodegeneration: report from India","volume":"26","author":"Mahale","year":"2023","journal-title":"Ann. Indian Acad. Neurol."},{"key":"10.1016\/j.phrs.2026.108193_bib14","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/ajmg.a.63076","article-title":"Progressive brain atrophy and severe neurodevelopmental phenotype in siblings with biallelic COASY variants","volume":"191","author":"Rosati","year":"2023","journal-title":"Am. J. Med. Genet. Part A"},{"key":"10.1016\/j.phrs.2026.108193_bib15","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1038\/s41431-018-0233-0","article-title":"Biallelic loss of function variants in COASY cause prenatal onset pontocerebellar hypoplasia, microcephaly, and arthrogryposis","volume":"26","author":"van Dijk","year":"2018","journal-title":"Eur. J. Hum. Genet"},{"key":"10.1016\/j.phrs.2026.108193_bib16","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1002\/ajmg.a.62768","article-title":"COASY related pontocerebellar hypoplasia type 12: A common Indian mutation with expansion of the phenotypic spectrum","volume":"188","author":"Mishra","year":"2022","journal-title":"Am. J. Med. Genet. Part A"},{"key":"10.1016\/j.phrs.2026.108193_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41421-023-00641-0","article-title":"COASY variant as a new genetic cause of riboflavin-responsive lipid storage myopathy","volume":"10","author":"Zheng","year":"2024","journal-title":"Cell Discov."},{"key":"10.1016\/j.phrs.2026.108193_bib18","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.3390\/brainsci11081031","article-title":"Coenzyme a biochemistry: from neurodevelopment to neurodegeneration","volume":"11","author":"Mignani","year":"2021","journal-title":"Brain Sci."},{"key":"10.1016\/j.phrs.2026.108193_bib19","doi-asserted-by":"crossref","first-page":"9707","DOI":"10.3390\/ijms21249707","article-title":"Neuronal Ablation of CoA Synthase Causes Motor Deficits, Iron Dyshomeostasis, and Mitochondrial Dysfunctions in a CoPAN Mouse Model","volume":"21","author":"Di Meo","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2026.108193_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2024.1458475","article-title":"CoA synthase plays a critical role in neurodevelopment and neurodegeneration","volume":"18","author":"Cavestro","year":"2024","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.phrs.2026.108193_bib21","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s00018-025-05576-1","article-title":"Impaired mitochondrial integrity and compromised energy production underscore the mechanism underlying CoASY protein-associated neurodegeneration","volume":"82","author":"Shao","year":"2025","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.phrs.2026.108193_bib22","doi-asserted-by":"crossref","first-page":"126","DOI":"10.15698\/mic2015.04.196","article-title":"Modeling human Coenzyme A synthase mutation in yeast reveals altered mitochondrial function, lipid content and iron metabolism","volume":"2","author":"Berti","year":"2015","journal-title":"Micro Cell"},{"key":"10.1016\/j.phrs.2026.108193_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/glia.70017","article-title":"Fibroblasts and hiPS-Derived Astrocytes From CoPAN Patients Showed Different Levels of Iron Overload Correlated With Senescent Phenotype","author":"Cozzi","year":"2025","journal-title":"Glia"},{"key":"10.1016\/j.phrs.2026.108193_bib24","article-title":"Emerging Disease-Modifying Therapies in Neurodegeneration With Brain Iron Accumulation (NBIA) Disorders","volume":"0","author":"Iankova","year":"2021","journal-title":"Front. Neurol."},{"key":"10.1016\/j.phrs.2026.108193_bib25","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3390\/pharmaceutics15010202","article-title":"PPAR Gamma Agonist Leriglitazone Recovers Alterations Due to Pank2-Deficiency in hiPS-Derived Astrocytes","volume":"15","author":"Santambrogio","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.phrs.2026.108193_bib26","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.3390\/ijms24043201","article-title":"Development of PPAR\u03b3 Agonists for the Treatment of Neuroinflammatory and Neurodegenerative Diseases: Leriglitazone as a Promising Candidate","volume":"24","author":"Pizcueta","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2026.108193_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.105162","article-title":"PPAR gamma agonist leriglitazone improves frataxin-loss impairments in cellular and animal models of Friedreich Ataxia","volume":"148","author":"Rodr\u00edguez-Pascau","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.phrs.2026.108193_bib28","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abc0555","article-title":"The brain penetrant PPAR\u03b3 agonist leriglitazone restores multiple altered pathways in models of X-linked adrenoleukodystrophy","volume":"13","author":"Rodr\u00edguez-Pascau","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.phrs.2026.108193_bib29","doi-asserted-by":"crossref","first-page":"7730","DOI":"10.1038\/s41467-024-51884-8","article-title":"Cannabidiol ameliorates mitochondrial disease via PPAR\u03b3 activation in preclinical models","volume":"15","author":"Puighermanal","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2026.108193_bib30","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1186\/s12967-023-04622-5","article-title":"Mitochondrial modulation with leriglitazone as a potential treatment for Rett syndrome","volume":"21","author":"Musokhranova","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.phrs.2026.108193_bib31","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000200034","article-title":"Efficacy and Safety of Leriglitazone in Patients With Friedreich Ataxia","volume":"8","author":"Pandolfo","year":"2022","journal-title":"Neurol. Genet"},{"key":"10.1016\/j.phrs.2026.108193_bib32","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1474-4422(22)00495-1","article-title":"Safety and efficacy of leriglitazone for preventing disease progression in men with adrenomyeloneuropathy (ADVANCE): a randomised, double-blind, multi-centre, placebo-controlled phase 2\u20133 trial","volume":"22","author":"K\u00f6hler","year":"2023","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.phrs.2026.108193_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103265","article-title":"Safety and efficacy of leriglitazone in childhood cerebral adrenoleukodystrophy (NEXUS): an interim analysis of an open-label, phase 2\/3 trial","volume":"84","author":"Garc\u00eda-Cazorla","year":"2025","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.phrs.2026.108193_bib34","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1002\/psp4.13132","article-title":"Clinical pharmacokinetics of leriglitazone and a translational approach using PBPK modeling to guide the selection of the starting dose in children","volume":"13","author":"Traver","year":"2024","journal-title":"CPT Pharmacomet. Syst. Pharm."},{"key":"10.1016\/j.phrs.2026.108193_bib35","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1002\/dvg.20777","article-title":"Efficient inducible Pan-neuronal cre-mediated recombination in SLICK-H transgenic mice","volume":"49","author":"Heimer-McGinn","year":"2011","journal-title":"Genesis"},{"key":"10.1016\/j.phrs.2026.108193_bib36","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nrn2652","article-title":"Tests to assess motor phenotype in mice: a user\u2019s guide","volume":"10","author":"Brooks","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.phrs.2026.108193_bib37","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1006\/prep.2000.1212","article-title":"Functional and immunological analysis of recombinant mouse H- and L-Ferritins from Escherichia coli","volume":"19","author":"Santambrogio","year":"2000","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.phrs.2026.108193_bib38","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1186\/s12859-018-2486-6","article-title":"iDEP: an integrated web application for differential expression and pathway analysis of RNA-Seq data","volume":"19","author":"Ge","year":"2018","journal-title":"BMC Bioinforma."},{"key":"10.1016\/j.phrs.2026.108193_bib39","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1093\/bioinformatics\/btz931","article-title":"ShinyGO: a graphical gene-set enrichment tool for animals and plants","volume":"36","author":"Ge","year":"2020","journal-title":"Bioinformatics"},{"key":"10.1016\/j.phrs.2026.108193_bib40","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.phrs.2026.108193_bib41","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41582-018-0058-z","article-title":"Neurofilaments as biomarkers in neurological disorders","volume":"14","author":"Khalil","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.phrs.2026.108193_bib42","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1093\/toxres\/tfad063","article-title":"Plasma neurofilament light chain as a potential biomarker of neurodegeneration in murine brain","volume":"12","author":"Sano","year":"2023","journal-title":"Toxicol. Res."},{"key":"10.1016\/j.phrs.2026.108193_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2020.00198","article-title":"Overview of general and discriminating markers of differential microglia phenotypes","volume":"14","author":"Jurga","year":"2020","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.phrs.2026.108193_bib44","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.3390\/ijms25073995","article-title":"Neuroinflammation in neurodegenerative disorders: current knowledge and therapeutic implications","volume":"25","author":"Giri","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2026.108193_bib45","doi-asserted-by":"crossref","first-page":"4312","DOI":"10.1210\/jc.2004-0190","article-title":"Effect of pioglitazone on circulating adipocytokine levels and insulin sensitivity in type 2 diabetic patients","volume":"89","author":"Miyazaki","year":"2004","journal-title":"J. Clin. Endocrinol. & Metab."},{"key":"10.1016\/j.phrs.2026.108193_bib46","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1186\/s12974-020-02037-3","article-title":"CCL3 contributes to secondary damage after spinal cord injury","volume":"17","author":"Pelisch","year":"2020","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.phrs.2026.108193_bib47","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.bbi.2021.05.013","article-title":"TLR2- and TLR3-activated microglia induce different levels of neuronal network dysfunction in a context-dependent manner","volume":"96","author":"Schilling","year":"2021","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.phrs.2026.108193_bib48","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13565","article-title":"Microglial cathepsin E plays a role in neuroinflammation and amyloid \u03b2 production in Alzheimer\u2019s disease","volume":"21","author":"Xie","year":"2022","journal-title":"Aging Cell"},{"key":"10.1016\/j.phrs.2026.108193_bib49","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","article-title":"Role of neuroinflammation in neurodegeneration development","volume":"8","author":"Zhang","year":"2023","journal-title":"Sig Transduct. Target Ther."},{"key":"10.1016\/j.phrs.2026.108193_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2024.1347987","article-title":"The role of neuroinflammation in neurodegenerative diseases: current understanding and future therapeutic targets","volume":"16","author":"Adamu","year":"2024","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.phrs.2026.108193_bib51","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1093\/brain\/awr042","article-title":"Novel histopathologic findings in molecularly-confirmed pantothenate kinase-associated neurodegeneration","volume":"134","author":"Kruer","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.phrs.2026.108193_bib52","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1365-2990.2012.01269.x","article-title":"Pantothenate kinase-associated neurodegeneration is not a synucleinopathy","volume":"39","author":"Li","year":"2013","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.phrs.2026.108193_bib53","doi-asserted-by":"crossref","unstructured":"M.C. Kruer, The Neuropathology of Neurodegeneration with Brain Iron Accumulation, in: International Review of Neurobiology, Elsevier, 2013: pp. 165\u2013194. https:\/\/doi.org\/10.1016\/B978-0-12-410502-7.00009-0.","DOI":"10.1016\/B978-0-12-410502-7.00009-0"},{"key":"10.1016\/j.phrs.2026.108193_bib54","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1042\/CS20230513","article-title":"The complement system in neurodegenerative diseases","volume":"138","author":"Nimmo","year":"2024","journal-title":"Clin. Sci."},{"key":"10.1016\/j.phrs.2026.108193_bib55","article-title":"Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function","author":"Spiteri","year":"2021","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.phrs.2026.108193_bib56","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/s41392-023-01628-9","article-title":"Astrocytes in human central nervous system diseases: a frontier for new therapies","volume":"8","author":"Verkhratsky","year":"2023","journal-title":"Sig Transduct. Target Ther."},{"key":"10.1016\/j.phrs.2026.108193_bib57","doi-asserted-by":"crossref","DOI":"10.1242\/dev.174698","article-title":"Rapid clearance of cellular debris by microglia limits secondary neuronal cell death after brain injury in vivo","volume":"146","author":"Herzog","year":"2019","journal-title":"Development"},{"key":"10.1016\/j.phrs.2026.108193_bib58","doi-asserted-by":"crossref","DOI":"10.1111\/bpa.12996","article-title":"Dysregulated protein phosphorylation: a determining condition in the continuum of brain aging and Alzheimer\u2019s disease","volume":"31","author":"Ferrer","year":"2021","journal-title":"Brain Pathol."},{"key":"10.1016\/j.phrs.2026.108193_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2015.00161","article-title":"Global and local missions of cAMP signaling in neural plasticity, learning, and memory","volume":"6","author":"Lee","year":"2015","journal-title":"Front. Pharm."},{"key":"10.1016\/j.phrs.2026.108193_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2021.788695","article-title":"Lipid metabolism influence on neurodegenerative disease progression: is the vehicle as important as the cargo?","volume":"14","author":"Estes","year":"2021","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.phrs.2026.108193_bib61","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202350435","article-title":"The vitamin B5\/coenzyme A axis: a target for immunomodulation?","volume":"53","author":"Miallot","year":"2023","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.phrs.2026.108193_bib62","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/ncomms2270","article-title":"PPAR\u03b3 is an E3 ligase that induces the degradation of NF\u03baB\/p65","volume":"3","author":"Hou","year":"2012","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2026.108193_bib63","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.2741\/2802","article-title":"Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists","volume":"13","author":"Kapadia","year":"2008","journal-title":"Front Biosci."},{"key":"10.1016\/j.phrs.2026.108193_bib64","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/jnc.12244","article-title":"Inflammation alters the expression of DMT1, FPN1 and hepcidin, and it causes iron accumulation in central nervous system cells","volume":"126","author":"Urrutia","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.phrs.2026.108193_bib65","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.tox.2013.09.015","article-title":"Acute iron overload and oxidative stress in brain","volume":"314","author":"Piloni","year":"2013","journal-title":"Toxicology"},{"key":"10.1016\/j.phrs.2026.108193_bib66","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3390\/biomedicines14010069","article-title":"Coenzyme A in brain biology and neurodegeneration","volume":"14","author":"Zhang","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.phrs.2026.108193_bib67","doi-asserted-by":"crossref","first-page":"6024","DOI":"10.3390\/ijms26136024","article-title":"Rare movement disorders\u2014An approach for clinicians","volume":"26","author":"Jesuthasan","year":"2025","journal-title":"Int. J. Mol. Sci."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826001088?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826001088?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T21:44:08Z","timestamp":1778795048000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661826001088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":67,"alternative-id":["S1043661826001088"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2026.108193","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PPAR\u03b3 activation by leriglitazone counteracts neurodegeneration and neuroinflammation in a disease-relevant mouse model of COASY dysfunction","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2026.108193","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108193"}}